Volume 2, Issue 4 , Pages 207-215, December 2006
Nano hemostat solution: immediate hemostasis at the nanoscale
Abstract
Hemostasis is a major problem in surgical procedures and after major trauma. There are few effective methods to stop bleeding without causing secondary damage. We used a self-assembling peptide that establishes a nanofiber barrier to achieve complete hemostasis immediately when applied directly to a wound in the brain, spinal cord, femoral artery, liver, or skin of mammals. This novel therapy stops bleeding without the use of pressure, cauterization, vasoconstriction, coagulation, or cross-linked adhesives. The self-assembling solution is nontoxic and nonimmunogenic, and the breakdown products are amino acids, which are tissue building blocks that can be used to repair the site of injury. Here we report the first use of nanotechnology to achieve complete hemostasis in less than 15 seconds, which could fundamentally change how much blood is needed during surgery of the future.
Key words: Hemostasis, Surgery, Trauma, Nanotechnology, Self-assembling peptide
To access this article, please choose from the options below
The authors declare a competing financial interest: S.Z. is a co-founder and board member of 3D Matrix, the provider of one of the materials used.
This work was supported by grants from the Deshpande Center for Technological Innovation at the Massachusetts Institute of Technology and the Research Grant Council (RGC) of Hong Kong.
PII: S1549-9634(06)00108-0
doi:10.1016/j.nano.2006.08.001
© 2006 Published by Elsevier Inc.
Volume 2, Issue 4 , Pages 207-215, December 2006
